Form 4: Verizon Executive Kyle Malady Sells 20,000 Shares

Verizon's EVP and Group CEO, Kyle Malady, sold 20,000 shares of company stock on January 28, 2025, at an average price of $40.49 per share.

Summary

• Kyle Malady, an Executive Vice President and Group CEO at Verizon, sold 20,000 shares of Verizon Communications Inc. stock on January 28, 2025.
• The sale was executed at a weighted average price of $40.49 per share.
• The prices for the shares sold ranged from $40.38 to $40.60.
• Following the transaction, Mr. Malady directly owns 25,675 shares and indirectly owns 18,106 shares through a 401(k).

Sentiment

Score: 5

Explanation: The document is neutral, reporting a standard stock sale by an executive. It doesn't indicate positive or negative sentiment.

Industry Context

This is a routine Form 4 filing, which is common for corporate executives who trade their company's stock. It provides transparency into insider transactions.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading.
• The sale by Kyle Malady is similar to other executive stock transactions at comparable companies such as AT&T and T-Mobile, where executives regularly buy and sell shares.

Stakeholder Impact

• The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's overall performance.

Key Dates

Keywords

Verizon, Kyle Malady, stock sale, executive, insider trading, share transaction, VZ